Opaleye Management as of Dec. 31, 2020
Portfolio Holdings for Opaleye Management
Opaleye Management holds 59 positions in its portfolio as reported in the December 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Ocular Therapeutix (OCUL) | 17.6 | $135M | 6.5M | 20.70 | |
Protara Therapeutics Com Stk (TARA) | 8.1 | $62M | 2.6M | 24.21 | |
Eidos Therapeutics | 5.4 | $42M | 316k | 131.58 | |
Eton Pharmaceuticals (ETON) | 4.3 | $33M | 4.0M | 8.13 | |
Codexis (CDXS) | 4.0 | $31M | 1.4M | 21.83 | |
Cardiff Oncology (CRDF) | 3.9 | $30M | 1.7M | 17.99 | |
Tracon Pharmaceuticals Com New (TCON) | 3.8 | $30M | 2.5M | 11.70 | |
Chemocentryx | 2.8 | $22M | 350k | 61.92 | |
Acutus Medical (AFIB) | 2.8 | $22M | 750k | 28.81 | |
Harrow Health (HROW) | 2.7 | $21M | 3.1M | 6.86 | |
Tg Therapeutics (TGTX) | 2.6 | $20M | 388k | 52.02 | |
Xoma Corp Del Com New (XOMA) | 2.6 | $20M | 455k | 44.13 | |
Neoleukin Therapeutics | 2.6 | $20M | 1.4M | 14.10 | |
Chimerix (CMRX) | 2.5 | $19M | 4.0M | 4.83 | |
Celldex Therapeutics Com New (CLDX) | 2.3 | $17M | 992k | 17.52 | |
Stereotaxis Com New (STXS) | 2.0 | $15M | 3.0M | 5.09 | |
Deciphera Pharmaceuticals (DCPH) | 1.7 | $13M | 222k | 57.07 | |
Fortress Biotech | 1.6 | $12M | 3.9M | 3.17 | |
Cytokinetics Com New (CYTK) | 1.6 | $12M | 583k | 20.78 | |
Myovant Sciences | 1.4 | $11M | 683k | 15.37 | |
Lumos Pharma (LUMO) | 1.3 | $10M | 281k | 35.71 | |
Seres Therapeutics (MCRB) | 1.3 | $9.8M | 335k | 29.24 | |
Biohaven Pharmaceutical Holding | 1.3 | $9.8M | 114k | 85.71 | |
Kalvista Pharmaceuticals (KALV) | 1.2 | $8.9M | 470k | 18.99 | |
Vaxcyte (PCVX) | 1.2 | $8.9M | 335k | 26.57 | |
Macrogenics (MGNX) | 1.1 | $8.5M | 371k | 22.86 | |
Fs Dev Corp Com Cl A | 1.0 | $7.7M | 704k | 11.00 | |
Protagonist Therapeutics (PTGX) | 0.9 | $7.0M | 260k | 27.00 | |
Sutro Biopharma (STRO) | 0.9 | $7.0M | 322k | 21.71 | |
Cerecor | 0.9 | $6.9M | 2.6M | 2.64 | |
Tricida | 0.9 | $6.8M | 959k | 7.05 | |
Infinity Pharmaceuticals (INFIQ) | 0.9 | $6.7M | 3.2M | 2.12 | |
Five Prime Therapeutics | 0.8 | $6.5M | 382k | 17.01 | |
Adamas Pharmaceuticals | 0.8 | $6.4M | 1.5M | 4.33 | |
Merus N V (MRUS) | 0.8 | $6.2M | 353k | 17.53 | |
Sio Gene Therapies | 0.7 | $5.6M | 2.0M | 2.78 | |
Tela Bio (TELA) | 0.7 | $5.5M | 365k | 15.04 | |
Fibrogen (FGEN) | 0.7 | $5.5M | 147k | 37.09 | |
Verastem | 0.6 | $4.8M | 2.3M | 2.05 | |
Mei Pharma Com New | 0.5 | $4.1M | 1.6M | 2.64 | |
Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.5 | $4.0M | 224k | 17.67 | |
Kezar Life Sciences (KZR) | 0.5 | $3.7M | 708k | 5.22 | |
Aptose Biosciences Com New | 0.5 | $3.5M | 800k | 4.38 | |
Praxis Precision Medicines I | 0.5 | $3.5M | 63k | 55.02 | |
Rhythm Pharmaceuticals (RYTM) | 0.4 | $3.4M | 115k | 29.73 | |
Edap Tms Sa Sponsored Adr (EDAP) | 0.4 | $3.4M | 658k | 5.17 | |
Essa Pharma Com New (EPIX) | 0.4 | $3.4M | 284k | 11.93 | |
Concert Pharmaceuticals I equity | 0.4 | $3.2M | 254k | 12.64 | |
Contrafect Corp Com New | 0.3 | $2.2M | 440k | 5.05 | |
Optinose (OPTN) | 0.2 | $1.8M | 435k | 4.14 | |
Sierra Oncology Com New | 0.2 | $1.2M | 75k | 16.03 | |
Amarin Corp Sponsored Adr New (AMRN) | 0.1 | $1.1M | 225k | 4.89 | |
Fulcrum Therapeutics (FULC) | 0.1 | $1.0M | 88k | 11.71 | |
Catalyst Biosciences Com New | 0.1 | $939k | 149k | 6.31 | |
Akouos | 0.1 | $901k | 46k | 19.82 | |
Catabasis Pharmaceuticals Com New | 0.1 | $402k | 188k | 2.14 | |
Magenta Therapeutics | 0.0 | $375k | 48k | 7.84 | |
Aveo Biosciences Com New | 0.0 | $339k | 59k | 5.77 | |
Biolinerx Sponsored Ads (BLRX) | 0.0 | $42k | 17k | 2.52 |